RBM10 and neoplasm: Quantification of differential splicing events between tumor clusters and normal tissues showed that clusters harboring mutations in U2AF1, RBM10, and CMTR2 had significantly more splicing alterations than WT tumors (Fig. 3b and Supplementary Fig. 6b).